Calleja, José Luis

Vidal-González, Judit; Martínez, Javier; Mulay, Akhilesh; López, Marta; Baiges, Anna; Elmahdy, Ahmed; Lampichler, Katharina; Maleux, Geert; Chang, Johannes; Poncela, Marta; Low, Gavin; Ghigliazza, Gabriele; Zipprich, Alexander; Picón, Carmen; Shah, Rushabh; Llop, Elba; Darnell, Anna; Maurer, Martin H; Bonne, Lawrence; Ramón, Enrique; ... (2024). Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis. JHEP reports, 6(2) Elsevier 10.1016/j.jhepr.2023.100977

Magaz, Marta; Giudicelli-Lett, Heloïse; Nicoară-Farcău, Oana; Rajoriya, Neil; Goel, Ashish; Raymenants, Karlien; Hillaire, Sophie; Crespo, Gonzalo; Téllez, Luis; Elkrief, Laure; Fondevila, Constantino; Orts, Lara; Nery, Filipe; Shukla, Akash; Larrue, Hélène; Fundora, Yiliam; Degroote, Helena; Aguilera, Victoria; LLop, Elba; Turco, Laura; ... (2023). Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome. Transplantation, 107(6), pp. 1330-1340. Lippincott Williams & Wilkins 10.1097/TP.0000000000004444

Praktiknjo, Michael; Simón-Talero, Macarena; Römer, Julia; Roccarina, Davide; Martínez, Javier; Lampichler, Katharina; Baiges, Anna; Low, Gavin; Llop, Elba; Maurer, Martin H.; Zipprich, Alexander; Triolo, Michela; Maleux, Geert; Fialla, Annette Dam; Dam, Claus; Vidal-González, Judit; Majumdar, Avik; Picón, Carmen; Toth, Daniel; Darnell, Anna; ... (2020). Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. Journal of hepatology, 72(6), pp. 1140-1150. Elsevier 10.1016/j.jhep.2019.12.021

Manns, Michael; Samuel, Didier; Gane, Edward J; Mutimer, David; McCaughan, Geoff; Buti, Maria; Prieto, Martín; Calleja, José Luis; Peck-Radosavljevic, Markus; Müllhaupt, Beat; Agarwal, Kosh; Angus, Peter; Yoshida, Eric M; Colombo, Massimo; Rizzetto, Mario; Dvory-Sobol, Hadas; Denning, Jill; Arterburn, Sarah; Pang, Phillip S; Brainard, Diana; ... (2016). Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial. Lancet infectious diseases, 16(6), pp. 685-697. Elsevier 10.1016/S1473-3099(16)00052-9